Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers
PHASE1
Study to establish the bioequivalence of a new formulation of Asasantin ER ...
Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
PHASE4
Comparison of pharmacokinetics of dipyridamole administered as Aggrenox ver...
Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects
PHASE1
Comparative Pharmacokinetics of Asasantin Extended Release (ER) and of imme...